Sara Masmoudi Recognized as One of Forbes Middle East's "Top Healthcare Leaders 2025"
Sara Masmoudi, CEO of the Kilani Group, has been named one of Forbes Middle East's "Top Healthcare Leaders 2025", acknowledging her influence and leadership in the healthcare and pharmaceutical industries. Since 2019, Masmoudi has led the Kilani Group, a Tunisian conglomerate with diversified activities covering pharmacy, healthcare, food, distribution, and retail. Under her direction, the group has consolidated its local and international presence through its key subsidiaries, including ADWYA, TERIAK, and PROTIS in the pharmaceutical and healthcare sectors, as well as Argania, Nerolia, and Prochidia for distribution, and Fatales in retail. Beyond her roles within the Kilani Group, Sara Masmoudi chairs TERIAK, ADWYA, and STA. She is also the head of the Tunisian Union of Pharma Industry and the founder of Pharma In Cluster, an initiative aimed at strengthening innovation and collaboration in the Tunisian pharmaceutical sector. Her influence extends beyond African borders, with CEO responsibilities for Cinpharm in Cameroon and Cipharm in Côte d'Ivoire, solidifying her role as a major figure in the pharmaceutical industry in Francophone Africa. Forbes Middle East highlights Masmoudi's impact on the strategic and operational development of her companies, as well as her ability to transform the healthcare and pharmacy landscape in the region.
